Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inger L Meek

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 20, 2014
[A woman with an eschar]Marvin A H Berrevoets, Inger L Meek, Quirijn de Mast
BMC Musculoskeletal Disorders|June 3, 2014
Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohortInger L Meek, Harald E Vonkeman, Mart Afj van de Laar
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular RisksInger L Meek, Mart A F J Van de Laar, Harald E Vonkeman
BMC Musculoskeletal Disorders|May 1, 2014
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literatureInger L Meek, Harald E Vonkeman, Mart A F J van de Laar
Nederlands Tijdschrift Voor Geneeskunde|July 24, 2014
[Systemic sclerosis: a multisystem disease]Marvin A H Berrevoets, Joekie Markhorst, Inger L Meek, et al.
Rheumatology (Oxford, England)|August 1, 2012
Increased cardiovascular risk factors in different rheumatic diseases compared with the general populationInger L Meek, H Susan J Picavet, Harald E Vonkeman, et al.
Arthritis Research & Therapy|January 5, 2021
Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort studyDaphne C Rohrich, Eline H M van de Wetering, Alexander J Rennings, et al.
BMC Rheumatology|May 31, 2022
Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort studyFrouwke Veenstra, Lise M Verhoef, Merel Opdam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled TrialMarjan Ghiti Moghadam, Harald E Vonkeman, Peter M Ten Klooster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|March 20, 2014
[A woman with an eschar]Marvin A H Berrevoets, Inger L Meek, Quirijn de Mast
BMC Musculoskeletal Disorders|June 3, 2014
Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohortInger L Meek, Harald E Vonkeman, Mart Afj van de Laar
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular RisksInger L Meek, Mart A F J Van de Laar, Harald E Vonkeman
BMC Musculoskeletal Disorders|May 1, 2014
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literatureInger L Meek, Harald E Vonkeman, Mart A F J van de Laar
Nederlands Tijdschrift Voor Geneeskunde|July 24, 2014
[Systemic sclerosis: a multisystem disease]Marvin A H Berrevoets, Joekie Markhorst, Inger L Meek, et al.
Rheumatology (Oxford, England)|August 1, 2012
Increased cardiovascular risk factors in different rheumatic diseases compared with the general populationInger L Meek, H Susan J Picavet, Harald E Vonkeman, et al.
Arthritis Research & Therapy|January 5, 2021
Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort studyDaphne C Rohrich, Eline H M van de Wetering, Alexander J Rennings, et al.
BMC Rheumatology|May 31, 2022
Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort studyFrouwke Veenstra, Lise M Verhoef, Merel Opdam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled TrialMarjan Ghiti Moghadam, Harald E Vonkeman, Peter M Ten Klooster, et al.
Pageof 1